Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CATB | OTLK | LTRN | ||
| Company | Catabasis Pharma | Outlook Therapeutics Inc | Lantern Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.21 | 1.4200 | 3.04 | ||
| High | 9.21 | 1.5300 | 3.17 | ||
| Low | 8.46 | 1.3607 | 3.02 | ||
| Last | 8.54 | 1.4700 | 3.13 | ||
| Change | -0.64 | +0.0500 | +0.11 | ||
| % Change | -6.97% | +3.52% | +3.48% | ||
| Volume | 98,800 | 516,600 | 39,100 | ||
| 20-Day Average Volume | 395,311 | 4,697,485 | 71,880 | ||
| Previous Close | 9.18 | 1.4200 | 3.02 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.72 | 1.7507 | 3.44 | ||
| 20-Day Raw Stochastic | 56.46% | 14.02% | 6.15% | ||
| 20-Day Relative Strength | 43.24% | 24.59% | 44.66% | ||
| Weighted Alpha | -50.43 | -72.72 | -59.13 | ||
| Today's Opinion | 88% Sell | 100% Sell | 80% Sell | ||
| Previous Opinion | 72% Sell | 100% Sell | 80% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.34% since 08/31/21 | +2.08% since 12/17/24 | -8.89% since 12/17/24 | ||
| Low | 8.46 on 09/08/21 | 1.2600 on 12/23/24 | 3.01 on 12/23/24 | ||
| High | 10.26 on 09/02/21 | 1.5900 on 12/18/24 | 3.60 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | -8.17% since 08/06/21 | -70.78% since 11/22/24 | +1.46% since 11/22/24 | ||
| Low | 6.31 on 08/20/21 | 0.8700 on 11/27/24 | 3.00 on 11/25/24 | ||
| High | 10.26 on 09/02/21 | 5.1800 on 11/25/24 | 4.88 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | -34.10% since 06/08/21 | -73.66% since 09/24/24 | -22.65% since 09/24/24 | ||
| Low | 6.31 on 08/20/21 | 0.8700 on 11/27/24 | 2.79 on 11/21/24 | ||
| High | 15.72 on 06/16/21 | 6.9800 on 11/07/24 | 4.88 on 12/09/24 | ||
| 6-Month | |||||
| %Chg | -50.23% since 03/08/21 | -80.22% since 06/24/24 | -20.08% since 06/24/24 | ||
| Low | 6.31 on 08/20/21 | 0.8700 on 11/27/24 | 2.79 on 11/21/24 | ||
| High | 22.01 on 03/18/21 | 9.2500 on 07/17/24 | 5.10 on 07/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 33,337 | 33,592 | 32,571 | ||
| Shares Outstanding, K | 3,904 | 23,656 | 10,785 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -37,300,000 | -58,980,000 | -15,960,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -7,470,000 | 44,410,000 | -4,510,000 | ||
| 60-Month Beta | 1.66 | 0.47 | 1.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.83 on 08/14/24 | -0.42 on 11/07/24 | ||
| Latest Earnings Date | 08/09/21 | 12/27/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||